Concomitant Usage of H1‐Antihistamines and Immune Checkpoint Inhibitors on Cancer Patient Survival
The benefits of adjunctive use of H1-antihistamines may be generation- and tumor-dependent. Further clinical and mechanistic studies are required to confirm the findings.
Authors
- Terry Cheuk‐Fung Yip (ORCID: https://orcid.org/0000-0002-1819-2464)
- Rashid Nok-Shun Lui (ORCID: https://orcid.org/0000-0003-1277-9595)
- Stephen L. Chan (ORCID: https://orcid.org/0000-0001-8998-5480)
- Tony S.K. Mok (ORCID: https://orcid.org/0000-0002-8251-0551)
- Vicki Wing‐Ki Hui (ORCID: https://orcid.org/0000-0002-6538-4098)
- Grace Lai–Hung Wong (ORCID: https://orcid.org/0000-0002-2863-9389)
- Vincent Wai‐Sun Wong (ORCID: https://orcid.org/0000-0003-2215-9410)
- Y. H. Leung (ORCID: https://orcid.org/0000-0002-6758-6400)
- Henry Lik‐Yuen Chan
Institutions
- Chinese University of Hong Kong (HK)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1002/cam4.70583
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.14